Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01240174 · ClinicalTrials.gov registry record · NA
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT01240174 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 400 participants.
The verdict
NCT01240174, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
Studies show, guidelines state, and performance measures assert that antibiotic prescribing for uncomplicated acute bronchitis is inappropriate. However, clinicians prescribe antimicrobials in over 60% of the 22.5 million acute bronchitis visits in the United States each year. Previous successful interventions have only reduced the antimicrobial prescribing rate to 40% or 50%. It is unknown if the antimicrobial prescribing rate for acute bronchitis can be brought to near zero percent in actual practice while maintaining patient safety and satisfaction. The goal of this study is to develop an Electronic Health Record (EHR)-integrated algorithm for the diagnosis and treatment of adults with acute bronchitis with a goal of reducing the antibiotic prescribing rate to near zero percent.
Interventions
- BEHAVIORAL Demonstration of near zero antibiotic prescribing for patients with acute bronchitis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01240174
The ClinicalTrials.gov registry entry for NCT01240174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Demonstration of near zero antibiotic prescribing for patients with acute bronchitis is the first listed.
NCT01240174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01240174 about?
NCT01240174 is a clinical study titled "Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis". Studies show, guidelines state, and performance measures assert that antibiotic prescribing for uncomplicated acute bronchitis is inappropriate. However, clinicians prescribe antimicrobials in over 60% of the 22.5 million acute bronchitis visits in the United States each year. Previous successful in...
What is the current status of trial NCT01240174?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2011-03. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01240174?
The interventions under investigation include: Demonstration of near zero antibiotic prescribing for patients with acute bronchitis (BEHAVIORAL).
Who is sponsoring clinical trial NCT01240174?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.